Magnetic Resonance Cholangio-pancreatography (MRCP) for Suspected Bilio-pancreatic Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01538368|
Recruitment Status : Completed
First Posted : February 24, 2012
Last Update Posted : February 24, 2012
Deutsche Klinik fuer Diagnostik
Information provided by (Responsible Party):
Till Wehrmann, Deutsche Klinik fuer Diagnostik
The interpretation of Magnetic Resonance Cholangio-pancreatography (MRCP)-findings is primarily performed by radiologists who only in some cases have experience with the interpretation of endoscopic retrograde cholangiopancreatography (ERCP)-images. It is unclear if MRCP-interpretation by the radiologist is sufficient to decide which additional endoscopic procedures might be necessary in an individual case or if an additional MRCP-interpretation by the endoscopist renders any clinical impact.
|Condition or disease|
|Suspected Bilio-pancreatic Disease|
|Study Type :||Observational|
|Actual Enrollment :||155 participants|
|Official Title:||Magnetic Resonance Cholangio-pancreatography (MRCP) for Suspected Bilio-pancreatic Disease: Should the Endoscopist Take a Second Look?|
|Study Start Date :||January 2007|
|Actual Primary Completion Date :||December 2009|
|Actual Study Completion Date :||December 2010|
Primary Outcome Measures :
- Endoscopic management [ Time Frame: 1 day ]Did the MRCP-interpretation by the gastroenterologist alter the scheduled endoscopic interventions ?
Secondary Outcome Measures :
- MRCP-interpretation [ Time Frame: 1 day ]Are there differences in the MRCP-interpreatation beween the radiologist and the gastroenterologist.
No Contacts or Locations Provided